We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CAPR market cap is 531.09M. The company's latest EPS is USD -0.4902 and P/E is -23.66.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.19M | 12.09M | 4.91M | 3.97M | 2.26M |
| Operating Income | -8.57M | -1.28M | -10.27M | -11.59M | -13.01M |
| Net Income | -6.39M | -763k | -9.79M | -11M | -12.56M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.01M | 310k | 245k | 2.55M | 25.18M |
| Operating Income | -7.73M | -13.69M | -20.94M | -29.7M | -24.08M |
| Net Income | -7.64M | -13.66M | -20.02M | -29.02M | -22.29M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 37.15M | 58.73M | 49.44M | 38.28M | 92.95M |
| Total Liabilities | 38.94M | 36.13M | 31.01M | 26.78M | 24.69M |
| Total Equity | -1.79M | 22.6M | 18.44M | 11.5M | 68.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.11M | 34.62M | 41.33M | 50.1M | 58.73M |
| Total Liabilities | 4.28M | 6.42M | 9.96M | 38.31M | 36.13M |
| Total Equity | 6.84M | 28.2M | 31.37M | 11.79M | 22.6M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14M | -25.6M | -1.27M | -13.56M | -25.2M |
| Investing | 10.97M | 5.11M | -9.5M | 5.19M | 7.2M |
| Financing | 2.41M | 25.58M | 2.29M | 4.36M | 71.68M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.82M | -10.05M | -16.81M | 4.92M | -25.6M |
| Investing | -3M | 5.44M | -1.2M | -35.07M | 5.11M |
| Financing | 9.18M | 33.38M | 20.23M | 4.87M | 25.58M |
| Market Cap | 531.09M |
| Price to Earnings Ratio | -23.66 |
| Price to Sales Ratio | 20.95 |
| Price to Cash Ratio | 35.89 |
| Price to Book Ratio | 23.34 |
| Dividend Yield | - |
| Shares Outstanding | 45.47M |
| Average Volume (1 week) | 973.14k |
| Average Volume (1 Month) | 1.43M |
| 52 Week Change | 82.50% |
| 52 Week High | 23.40 |
| 52 Week Low | 3.52 |
| Spread (Intraday) | 0.13 (1.11%) |
| Company Name | Capricor Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.capricor.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
